To the Editor I read with interest the insightful and balanced observation by Hamel and Selby.1 Some questions and issues arose, which I present to the authors:
Bearing in mind the low survival rates for stage IV (S4) non–small cell lung cancer (NSCLC), how long did the patient survive beyond the approximately 8 to 9 months (6-7 months of therapy and several weeks for elimination of iodine) you reported? One-year survival for stage IV disease is 17% and incalculable at 5 years owing to insufficient numbers surviving beyond 2 years.2 It could be useful to know how much longer and why he lived, in (apparently) reasonable condition, given his brain and liver metastases.
Nwabudike LC. Pustular Eruption (Iododerma?) in a Patient With Cancer Treated With Complementary and Alternative Medicine. JAMA Dermatol. Published online February 28, 2018. doi:10.1001/jamadermatol.2017.6164
Customize your JAMA Network experience by selecting one or more topics from the list below.